Viewing nowCombinationRodiante Tablets 40/2.5mg (Telmisartan, Escitalopram Nicotinate)
Telmisartan 40mg · S-Amlodipine Nicotinate 3.253mg
Tablet · Prescription medication · Combination
Hallym Pharmaceutical Co., Ltd.

MFDS item code 202104295 · Approved 2021.05.31 · Insurance code 645306540
Treatment of essential hypertension not controlled by monotherapy
This medication is used to lower and control blood pressure more effectively when monotherapy with escitalopram (amlodipine) or telmisartan is insufficient for patients with essential hypertension. This helps to reduce the risk of complications from hypertension and improve cardiovascular health.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before administering this medicine, it is recommended that the dose be adjusted using the individual components (S-amlodipine (amlodipine) or telmisartan). However, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/2.5mg: For patients whose blood pressure is not adequately controlled with 2.5mg of S-amlodipine (5mg of amlodipine) or 40mg of telmisartan. - 80/2.5mg: For patients whose blood pressure is not adequately controlled with 2.5mg of S-amlodipine (5mg of amlodipine) or this medicine 40/2.5mg. - 40/5mg: For patients whose blood pressure is not adequately controlled with 5mg of S-amlodipine (10mg of amlodipine). - 80/5mg: For patients whose blood pressure is not adequately controlled with 5mg of S-amlodipine (10mg of amlodipine) or this medicine 40/5mg. Patients taking telmisartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience (only for this medicine 40/2.5mg and 80/5mg). ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual dosage regimen of S-amlodipine (amlodipine) is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Administration with caution in the following patients’). In elderly patients aged 75 years or older, clearance of S-amlodipine (amlodipine) is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.
This medication can pose serious risks to the fetus, especially during the second and third trimesters of pregnancy, so it should not be taken by women who are pregnant or may become pregnant. Patients with allergies to any components of this drug, severely impaired liver or heart function, and those with certain heart conditions should not use it. Special caution is needed when using this medication in patients with impaired liver function, gastrointestinal diseases, decreased kidney function, and the elderly. Dizziness or a drop in blood pressure may occur during treatment, so caution is advised when driving or operating hazardous machinery. Due to the risk of increased potassium levels in the blood, those taking potassium supplements or certain diuretics should have their blood tests done frequently as directed by a physician. This medication may interact with other drugs, so it is essential to inform healthcare providers about any other medications being taken. In case of overdose, serious hypotension, dizziness, heart problems, etc. may occur, so seek appropriate medical treatment immediately by contacting a healthcare facility. Safety and effectiveness in children have not been established, and it is also advisable not to take this medication while breastfeeding. Keep this medication out of reach of children and do not transfer it to other containers for safety.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture. It is best to keep it at room temperature between 1 and 30 degrees Celsius.
Light blue and white biconvex oval tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · S-Amlodipine Nicotinate 3.253mg
Tablet · Prescription medication · Combination
Hallym Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · S-Amlodipine Nicotinate 6.506mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · S-Amlodipine Nicotinate 3.253mg
Tablet · Prescription medication · Combination
Hanlim Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · S-Amlodipine Nicotinate 6.506mg
Tablet · Prescription medication · Combination
Hallym Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.